Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,629.29
(
0.07%
)
US TECH 100
23,689.20
(
-0.45%
)
Dow Jones
46,216.47
(
-0.02%
)
Brent Oil
101.48
(
-4.79%
)
Bitcoin
70,355.93
(
-1.25%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 69394

Wednesday, 04/15/2009 2:20:17 PM

Wednesday, April 15, 2009 2:20:17 PM

Post# of 257259
Evotec’s EVT 302, a monoamine oxidase inhibitor, failed in a phase II proof-of-concept study for smoking cessation:

http://finance.yahoo.com/news/Evotec-Reports-Results-of-pz-14922331.html
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now